Amarin



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amarin USD -24415000 24.65M 2024-09
AstraZeneca USD 5.26B 597M 2024-12
DBV Technologies USD -27409000 2.3M 2024-09
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12



Amarin - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.